PharmaTher Inc.
  • HOME
  • COMPANY
    • Management
    • Board Of Directors
  • RESEARCH
    • Pipeline
    • Microneedle Delivery
    • KETABET
    • panaceAI
    • Patents
  • INVESTORS
  • NEWS
  • CONTACT
  • HOME
  • COMPANY
    • Management
    • Board Of Directors
  • RESEARCH
    • Pipeline
    • Microneedle Delivery
    • KETABET
    • panaceAI
    • Patents
  • INVESTORS
  • NEWS
  • CONTACT

About Us

PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat neuropsychiatric, neurodegenerative and pain disorders.
Our team includes world-class strategic partners, advisors and a strong leadership team with a proven track record
of success in drug development, business development and capital markets.  Our goal is to advance the development
of panaceAI™, our drug repurposing artificial intelligence platform, and advance our clinical product pipeline
​with ketamine and psilocybin in Parkinson’s disease, depression, traumatic brain injury and stroke.
Picture
Picture
Our team includes world-class strategic partners, advisors and a strong leadership team with a proven track record of success in drug development, business development and capital markets.  Our goal is to advance the development of panaceAI™, our drug repurposing artificial intelligence platform, and advance our clinical product pipeline ​with ketamine and psilocybin in Parkinson’s disease, depression, traumatic brain injury and stroke.
Picture

Connect With Us

Picture
Picture
PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario  Canada
M5C 1P1
Psychedelic Pharmaceuticals

COMPANY  /  RESEARCH  /  INVESTORS  /  NEWS  /  CONTACT


Publicly-traded on the CSE: PHRM and OTCQB: PHRRF
© COPYRIGHT 2021.  PharmaTher Holdings Ltd.   ALL RIGHTS RESERVED.